Tag: Brexit

UK Updated No-Deal Brexit Plans for Meds Supply

The government has announced plans to launch procurement exercises to secure freight capacity if the UK leaves the EU with no deal. The Department of Health and Social Care (DHSC) will lead a pro...

Sanofi Plans Fly Supply of Flu Vaccine to UK after Brexit

Drugs company Sanofi has plans to fly supplies of flu vaccine into the UK if other transport routes are disrupted after the country leaves the EU. Hugo Fry, the managing director of its UK arm, tol...

EMA Published Q&A for Brexit

EMA has published a questions-and-answers (Q&A) document for patients, healthcare professionals and the general public on the preparatory work that European Union authorities are doing to prevent ...

EMA’s Clearance about GMP Certificate Validation after Brexit

The European Medicines Agency (EMA) has updated the agency's Brexit-related guidance documents. These documents are supporting pharmaceutical companies in preparing for the United Kingdom's (UK) withd...

Ireland Not to Stockpile Med before Brexit

Ireland’s deputy prime minister on Tuesday called on people not to stockpile medicine before Britain quits the European Union, saying the country had at least eight weeks of supply and was moving to s...

UK and Israel Bilateral Trade Agreement

Economy Minister Eli Cohen and British Secretary of State for International Trade Liam Fox put pen to paper on a bilateral trade continuity agreement in Tel Aviv on Monday, less than 40 days before th...

No-Deal Brexit Could Lead to Fake Med in UK

Drugmakers warned on Friday that if Britain leaves the European Union without a deal next month Britons could miss out on an EU-wide system to fight counterfeit drugs that will go live on Saturday aft...

Brexit Could Hinder Access to CAR-T Therapies across Europe

Brexit and the rise of nationalism in Europe could hinder patients’ access to pricey CAR-T therapies across Europe, a conference heard. In England, the NHS, NICE and the government have joined forc...

Novartis Statement Regarding No-Deal Brexit

Novartis has issued a statement expressing concern over the state of medicine supply to the UK, and noting that it is building increased inventories across its portfolio of medicines in the UK. The...

No-Deal Brexit – Guidance for Clinical Trials

The U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) released further guidance on the regulation of medicines, medical devices and clinical trials if there is no Brexit deal. The scenar...

EMA Set Date for Moving from UK

The European Medicines Agency (EMA) has officially taken over its new building in Amsterdam in preparation of its move to the Dutch capital from London. EMA will leave its premises in London on 1 M...

UK Signs Contracts for Drug Storage in “no-deal” Brexit

Officials hope third contract for warehousing will be signed shortly, with total cost of £10m. The government has signed two contracts to secure warehouse space for the storage of drugs as part of ...

Potential Pitfalls of Brexit for Pharma

With less than 4 months remaining before the UK is scheduled to leave the EU in what is commonly referred to as “Brexit”, concerns are increasing within the pharmaceutical industry about the consequen...

Risk for Pharma after Brexit still Unknown

A ‘no deal’ Brexit will change and burden how all industries that move materials and goods across borders, including the pharmaceutical and medical device sectors, do business. Pharmaceutical compa...

Brexit Affects Supply and Prices in UK Pharmacies

The BBC’s 5 Live Breakfast reported that pharmacies are stockpiling generic drugs, and prices are fluctuating amid the political uncertainty. Manufacturers of branded drugs have been stockpiling th...

Ipsen Warns about Brexit Influence on Pharma

France’s Ipsen has become the latest pharma company to warn about the impact of Brexit on the pharma industry and patients’ access to medicines. As Theresa May attempts to drum up support for her B...